XAGE Longevity Health Holdings, Inc.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · OTC · SEC CIK 1842939 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY60.3%
TTM net income YoY5.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin59.0%
Operating margin-343.6%
Net margin-404.8%
FCF margin—
EBITDA margin-340.0%
Returns
ROE—
ROA-286.0%
ROIC (approx.)—
Asset turnover0.71x
Leverage & solvency
Liabilities / assets924.4%
Debt / equity—
Current ratio0.07x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.36x
Accruals ratio-183.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.91M | $50,318 | $0 | — | — |
| Cost of revenue | $818,051 | $6,357 | $0 | — | — |
| Gross profit | $1.09M | $43,961 | $0 | — | — |
| R&D expense | $788,888 | $1.05M | $2.50M | $2.20M | — |
| Operating income | -$7.11M | -$5.00M | -$5.94M | -$5.51M | -$467,431 |
| Interest expense | $18,214 | $29,446 | $33,527 | — | — |
| Pretax income | -$6.87M | -$10.75M | -$16.21M | -$9.05M | -$329,382 |
| Income tax | $36,262 | -$97,279 | $0 | $0 | $0 |
| Net income | -$6.91M | -$10.37M | -$15.45M | -$9.05M | -$329,382 |
| EBITDA | -$7.03M | -$4.92M | -$5.85M | -$5.41M | — |
| EPS (basic) | -4.83 | -14.56 | -1.46 | -5.47 | — |
| EPS (diluted) | -4.83 | -14.56 | -1.46 | -5.47 | — |
| Weighted avg. shares (diluted) | 1.43M | 712,091 | 11.02M | 1.76M | — |
| Balance sheet | |||||
| Cash & equivalents | $706,740 | $157,139 | $2.91M | $128,149 | $12,362 |
| Receivables | $36,500 | $4,096 | $0 | $0 | — |
| Inventory | $963,028 | $108,705 | $0 | $0 | — |
| Current assets | $1.95M | $955,554 | $62.90M | $605,540 | $973,175 |
| PP&E, net | $101,621 | $113,906 | $192,846 | $254,974 | — |
| Goodwill | — | — | — | $0 | — |
| Intangibles | $15,094 | $19,641 | $24,187 | $28,702 | — |
| Total assets | $2.37M | $1.47M | $63.95M | $1.75M | $155.42M |
| Current liabilities | $7.92M | $5.88M | $38.50M | $7.30M | $330,007 |
| Total liabilities | $8.23M | $6.19M | $39.20M | $8.12M | $5.74M |
| Shareholders' equity | -$5.87M | -$4.71M | $24.75M | -$37.79M | -$29.58M |
| Shares outstanding | 1.78M | 696,969 | 23.09M | 896,580 | — |
| Cash flow statement | |||||
| Operating cash flow | -$3.33M | -$3.89M | -$8.35M | -$3.43M | -$451,167 |
| Capital expenditure | $14,225 | — | $30,470 | $7,164 | — |
| Free cash flow | -$3.34M | — | -$8.38M | -$3.44M | — |
| Investing cash flow | -$164,225 | -$748,796 | -$30,470 | -$7,164 | — |
| Financing cash flow | $4.04M | $1.89M | $11.16M | $3.55M | $155.67M |
| Depreciation & amortization | $78,675 | $83,486 | $97,113 | $94,298 | — |
| Stock-based compensation | $692,790 | $827,043 | $667,682 | $636,368 | $0 |
| Share buybacks | — | — | $0 | $2,294 | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.